Category: Healthcare/Biotech

Novo Nordisk Signs Up to $1.4 Billion Deal With Orbis Medicines to Discover AI-Enabled Oral Drugs

Novo Nordisk is partnering with Danish biotechnology company Orbis Medicines in a drug discovery and licensing agreement worth up to

At Visionary Titans, we celebrate the leaders redefining industries and driving progress worldwide. Discover insights, success stories, and visionary perspectives that inspire transformation.

Explore Magazines

© 2026 All Rights Reserved.